Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With MRI
NCT07637266Recruiting
- Sponsor
- Clinical Hospital Center Zagreb
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Trial of del Nido cardioplegia in coronary artery disease (CAD) (2 arms), sponsored by Clinical Hospital Center Zagreb. Primary endpoint: Myocardial Viability Assessed by Magnetic Resonance Imaging at 4 weeks. Started Jun 2026; status: recruiting.
02
Drugs
del Nido cardioplegia
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07637266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07637266.